LEO Pharma Inc.
5 drugs in NADAC|0 Generic,5 Brand
LEO Pharma Inc. lists 5 NDCs in the CMS NADAC file (0 generic, 5 brand), at an average NADAC of $17.66 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
5
0G / 5B
Avg Price / Unit
$17.6629
$8.33 – $21.84
Avg 7d Change
-0.03%
Across 2 drugs with changes
7d Activity
of 5 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
calcipotriene and betamethasone dipropionate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Corticosteroid therapeutic class
Review the broader class where LEO Pharma Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does LEO Pharma Inc. make?
LEO Pharma Inc. lists 5 NDCs in the CMS NADAC file — 0 generic and 5 brand products.
What is the average price of LEO Pharma Inc. drugs?
The average NADAC across LEO Pharma Inc.'s portfolio is $17.6629 per unit, ranging from $8.3337 to $21.8397.
What types of drugs does LEO Pharma Inc. make?
LEO Pharma Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Corticosteroid (4), Vitamin D Analog (4).
Has LEO Pharma Inc. had any drug recalls?
No FDA enforcement recalls are matched to LEO Pharma Inc. in the openFDA feed.
How has LEO Pharma Inc.'s pricing changed recently?
Over the past 7 days, 1 LEO Pharma Inc. product rose and 1 fell, with a portfolio-wide average change of -0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ENSTILAR 0.005%-0.064% FOAM calcipotriene and betamethasone dipropionate | $21.8397 per GM | +0.01% |
TACLONEX 0.005%-0.064% SUSPENSION calcipotriene and betamethasone dipropionate | $20.7168 per GM | — |
TACLONEX 0.005%-0.064% SUSPENSION calcipotriene and betamethasone dipropionate | $20.6968 per GM | — |
ENSTILAR 0.005%-0.064% FOAM calcipotriene and betamethasone dipropionate | $16.7274 per GM | — |
FINACEA 15% FOAM azelaic acid | $8.3337 per GM | -0.07% |